Reuters logo
BRIEF-Biocon announces partnership with JDRF to support study of oral insulin drug candidate
September 6, 2017 / 5:33 AM / 15 days ago

BRIEF-Biocon announces partnership with JDRF to support study of oral insulin drug candidate

Sept 6 (Reuters) - Biocon Ltd

* Says JDRF supports biocon study of novel, fast-acting oral insulin tregopil for type 1 diabetes treatment Source text - bit.ly/2wEFaOf Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below